HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US Ad Watchdog Group May Allow Reopening Of Reviews With New Data

This article was originally published in The Pink Sheet & The Rose Sheet

Executive Summary

The private National Advertising Division is allowing marketers to petition to reopen closed cases if they have new studies or other data supporting ad claims, though the bar for re-review is high, says NAD Director Laura Brett.

You may also be interested in...

ACT Dry Mouth Claims Get Parched In Industry Self-Regulation Review

Biodene maker GSK challenged Sanofi's ACT Dry Mouth advertising and both companies find disappointments in the Better Business Bureaus' advertising division's review.

Citrucel Claim That Metamucil Causes Excess Gas Expelled After 20 Years

GlaxoSmithKline will discontinue claim P&G's Metamucil product causes excess gas and it Citrucel doesn't after P&G presented evidence that met NAD's standard for reopening a review. The industry self-regulation organization found GSK could no longer support its claim.

Supplement Claims Targeting Elderly, Weight Conscious Top FTC Priorities

Dubious supplement ad claims that have driven FTC enforcement in the sector for some time likely will continue as three commission seats are filled, says advertising practices official Richard Cleland.


Related Companies

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts